NCT04174118: A trial that was reported late by Dicerna Pharmaceuticals, Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04174118 |
|---|---|
| Title | A Phase 1/2 Ascending Dose, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Subcutaneously Administered DCR-A1AT in Healthy Adult Volunteers and Patients With Alpha1-Antitrypsin-Deficiency-Associated Liver Disease |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 24, 2019 |
| Completion date | Dec. 31, 2021 |
| Required reporting date | Dec. 31, 2022, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Feb. 2, 2021 |
| Days late | None |